Conexeu Sciences Inc. Common Stock CNXU
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $20.00 (+406.3% upside)
Key Stats
- Today's Range
- $3.40 – $4.05
- 50-Day Range
- $3.05 – $10.46
- 52-Week Range
- $3.05 – $18.79
- Volume
- 601K shs
- Average Volume
- 268K shs
- Market Cap
- $102.81 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.08%
- Days to Cover
- 1.00
About Conexeu Sciences Inc. Common Stock
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
Related Stocks
Compare head-to-head: CNXU vs STE·CNXU vs ZBH·CNXU vs MSA·CNXU vs SMTI
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.